2.8 Million Stock Options on Heels of Q1 Bomb2.8 million options (without saying how many went to C-suite execs and the Board) on the heels of a huge revenue miss and big swing to cash losses is unethical and telling. These never should have been "awarded". At best deferred until a return to profitbability and market prices for the shares that reflect that after the Q1 bomb.
Dec 22 2022 Press Release about Record Sales and Profits:
"Corporate Outlook Microbix will continue to drive sales growth across all of its three revenue-generating business lines, and work to keep improving percentage gross margins and driving bottom-line results."
At Dec 22/22 they had to know Q1 was looking to be a big miss. Read the long explanations now being given for the miss...the Q1 bomb was no big surprise to Mgmt or the Board when they made the fwd looking comment above.